跨导管大动脉生物假体中的结构损伤:诊断,发病和治疗
Sankalp P Patel1, Santiago Garcia2, Janarthanan Sathananthan3
1The NCH Heart Institute, NCH Healthcare System, Naples, Florida, USA.
Structural heart : the journal of the Heart Team
|June 5, 2023
概括
过导管大动脉置换 (TAVR) 是对大动脉狭窄的常见治疗方法. 了解生物假体退化对于改善TAVR耐用性和患者的治疗结果至关重要.
科学领域:
- 心脏病学 心脏病学
- 生物医学工程 生物医学工程
- 心脏门疾病 心脏门疾病
背景情况:
- 过导管大动脉置换 (TAVR) 是严重的大动脉狭窄症的领先治疗方法.
- 在年轻患者中越来越多的使用突显了生物假体门耐用性的重要性.
- 透导管与本地门恶化的病理生理学尚未完全理解.
研究的目的:
- 为了提供一个当代的跨导管结构退化的概述.
- 讨论病变发生,诊断和治疗中的新概念.
- 为了突出进一步研究膜退化机制和耐用性的需要.
主要方法:
- 综述当前关于跨导管生物假体变性病变的文献.
- 集成先进的多模式成像和侵入性血液动力学用于诊断.
- 对生物分子差异和影响变性的主体因素的分析.
主要成果:
- 退化机制与手术生物假体相似,但根据门结构设计而有所不同.
- 修订后的指导方针改善了生物假体退化的诊断和管理.
- 了解生物分子差异可以推进组织技术,以提高耐用性.
结论:
- 准确的诊断和对退行模式的理解是TAVR患者终身管理的关键.
- 需要进一步的研究来阐明生物分子差异,并优化膜退化治疗.
- 翻译研究和临床试验对于改善TAVR门耐用性至关重要.
相关概念视频
Aortic Regurgitation I: Introduction
19
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
19
Aortic Regurgitation III: Medical Management
26
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
26
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
33
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
33
Mitral Stenosis III: Medical Management
14
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
14
Mitral Regurgitation III: Medical Management
20
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
20
Mitral Valve Prolapse I: Introduction
23
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
23


